GetTopicDetailResponse(id=8ae8118e767, topicName=miR-29b, introduction=miR-29b, content=null, image=null, comments=3, allHits=1014, url=https://h5.medsci.cn/topic?id=11877, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=64272, tagList=[TagDto(tagId=64272, tagName=miR-29b)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2081264, encodeId=873c20812644b, content=<a href='/topic/show?id=8ae8118e767' target=_blank style='color:#2F92EE;'>#miR-29b#</a>, objectTitle=J Cell Mol Med：二型糖尿病視網(wǎng)膜病變患者血漿中的miR-29b和miR-200b水平, objectType=article, longId=154915, objectId=c7741549153b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7741549153b, replyNumber=0, likeNumber=86, createdTime=2019-10-25, rootId=0, userName=仁心濟(jì)世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7741549153b, moduleTitle=J Cell Mol Med：二型糖尿病視網(wǎng)膜病變患者血漿中的miR-29b和miR-200b水平, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c7741549153b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081265, encodeId=cd3720812653f, content=<a href='/topic/show?id=8ae8118e767' target=_blank style='color:#2F92EE;'>#miR-29b#</a>, objectTitle=Blood：靶向ROR1遞送miR-29b可誘導(dǎo)細(xì)胞周期阻滯，有望成為CLL的新療法, objectType=article, longId=167584, objectId=2c5616e584e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c5616e584e8, replyNumber=0, likeNumber=98, createdTime=2020-01-08, rootId=0, userName=仁心濟(jì)世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c5616e584e8, moduleTitle=Blood：靶向ROR1遞送miR-29b可誘導(dǎo)細(xì)胞周期阻滯，有望成為CLL的新療法, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2c5616e584e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081263, encodeId=54a720812630b, content=<a href='/topic/show?id=8ae8118e767' target=_blank style='color:#2F92EE;'>#miR-29b#</a>, objectTitle=Stemcells：EIF5A2可通過c-Myc/miR-29b軸維持CD133+的肝癌細(xì)胞的存活, objectType=article, longId=121439, objectId=8712121439b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8712121439b0, replyNumber=0, likeNumber=112, createdTime=2018-07-24, rootId=0, userName=仁心濟(jì)世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8712121439b0, moduleTitle=Stemcells：EIF5A2可通過c-Myc/miR-29b軸維持CD133+的肝癌細(xì)胞的存活, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8712121439b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
